Aptevo Therapeutics (NASDAQ:APVO) Releases Earnings Results, Beats Expectations By $0.26 EPS

Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($1.67) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.93) by $0.26, Zacks reports. Aptevo Therapeutics Price Performance Shares of Aptevo Therapeutics stock traded down $0.04 during trading on Friday, reaching $0.37. 134,978 shares of […]

Leave a Reply

Your email address will not be published.

Previous post Nantucket blasts Massachusetts state senator for leaving meeting early: ‘A disgrace’
Next post OLD National Bancorp IN Lowers Stake in MercadoLibre, Inc. (NASDAQ:MELI)